Determination of concentration of cytosolic NADH-cytochrome b5 reductase in erythrocytes from normal Chinese adults, neonates and patients with hereditary methemoglobinemia by double-antibody sandwich ELISA

Acta Haematologica

Volumn 100, Issue 1, 1998, Pages 44-48

  Lan, Fenghua ^a,b   Tang, Yuchai ^a   Huang, Changhui ^a   Zhu, Zhongyong ^a  

^a Dongfang Hospital   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Erythrocyte; Hereditary methemoglobinemia; NADH cytochrome b5 reductase; Sandwich ELISA

Indexed keywords

CYTOCHROME B5 REDUCTASE; METHEMOGLOBIN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; HEREDITARY METHEMOGLOBINEMIA; HUMAN; HUMAN CELL; MALE; NEWBORN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; CHINA; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; HUMANS; INFANT, NEWBORN; METHEMOGLOBINEMIA; RABBITS;

EID: 0031830078     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040862     Document Type: Article

References (26)

1. Tomatsu S, Kobayashi Y, Fukumaki Y, Yubisui T, Orii T, Sakaki Y: The organization of the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. Gene 1989;80:353-361.
2. Scott EM, Griffith IV: The enzymic defect of hereditary methemoglobinemia: Diaphorase. Biochim Biophys Acta 1959;34:584.
3. Leroux A, Junien C, Kaplan JC, Bamberger J: Generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Nature 1975;258: 619.
4. Shirabe K, Landi MT, Takeshita M, Uziel G, Fedrizz E, Borgese N: A novel point mutation in a 3′ splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia. Am J Hum Genet 1995; 57:302.
5. Mota Vieira M, Kaplan JC, Kahn A, Leroux A: Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood 1995;85:2254.
6. Jenkins MM, Prchal J: A novel mutation found in the 3' domain of NADH-cytochrome b5 reductase in an African-American family with type I congenital methemoglobinemia. Blood 1996;87:2993.
7. Manabe J, Arya R, Sumimoto H, Yubisui T, Bellingham AJ, Layton DM, Fukumaki Y: Two novel mutations in the red cell nicotinamide adenine dinucleotide (NADH) cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Blood 1996;88:3208.
8. Borgese N, D'Arrigo A, De Silvestris M, Pietrini G: NADH-cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of posttranslational targeting to the endoplasmic reticulum. FEBS Lett 1993;325:70.
9. Choury D, Leroux A, Kaplan JC: Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal subjects and methemoglobinemic patients. J Clin Invest 1981;67:149.
10. Takeshita M, Tamura M, Yubisui T, Toneyama Y: Exponential decay of cytochrome b5 and cytochrome b5 reductase during senescence of erythrocyte relates to the increased methemoglobin content. J Biochem (Tokyo) 1988;93: 931-934.
11. Mota Vieira L, Kaplan JC, Kahn A, Leroux A: The rat NADH-cytochrome b5 reductase transcripts resulting from multiple alternative first exons. Eur J Biochem 1994;220:729.
12. Choury D, Wajcman H, Boissel JP, Kaplan JC: Evidence for endogenous proteolytic solubilization of human red cell membrane NADH-cytochrome b5 reductase. FEBS Lett 1981;126: 172.
13. Pietrini G, Aggujaro D, Carrera P, Malyszko J, Vitale A, Borgese N: A single mRNA, transcribed from an alternative, erythroid-specific, promotor, codes for two non-myristylated forms of NADH-cytochrome b5 reductase. J Cell Biol 1992;117:975.
14. Chang HY, Wu SO: Congenital methemoglobinemia. Report of a case. Chin Med J 1954;72: 153.
15. Yang RF, He JY, Weng SL: Hereditary methemoglobinemia. Chin J Hemathol 1985;6:455.
16. Huang CH, Yu SL, Zhu ZY, He JY, Lu AW, Zhen QM: Alteration of NADH-cytochrome b5 reductase activity of erythrocytes and leukocytes in hereditary methemoglobinemia. Chin J Hematol 1993;14:408.
17. Lan FH, Tang Y, Huang CH, Zhu ZY: Establishment of monoclonal antibodies against human erythrocyte NADH-cytochrome b5 reductase. Hybridoma 1996;15:295.
18. Scott EM : The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia. J Clin Invest 1960;39:1176.
19. Nagai T, Shirabe K, Yubisui T, Takeshita M: Analysis of mutant NADH-cytochrome b5 reductase: Apparent 'type III' methemoglobinemia can be explained as type I with an unstable reductase. Blood 1993;81:808.
20. Borgese N, Pietrini G: Distribution of the integral membrane protein NADH-cytochrome b5 reductase in rat livers, studied with a quantitative radioimmunoblotting assay. Biochem J 1986;239:393.
21. Borgese N, Pietrini G, Gaetani S: Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. J Clin Invest 1987;80:1296.
22. Choury D, Reghis A, Pichard A-L, Kaplan J-C: Endogenous proteolysis of membrane-bound red cell cytochrome b5 reductase in adults and newborns: Its possible relevance to the generation of the soluble 'methemoglobin reductase'. Blood 1983;61:894.
23. Panin G, Pernechele M, Giurioli R, Secchieri S, Milanesi O, Pellegrino PA, Chiandetti L: Cytochrome b5 reductase activity in erythrocytes and leukocytes as related to sex and age. Clin Chem 1984;30:701.
24. Sass MD, Caruso CJ, Farhangi M: PTNH-methemoglobin reductase deficiency: A new red-cell enzyme defect. J Lab Clin Med 1967; 70:760.
25. Kaplan JC, Beutler E: Electrophoresis of red cell NADH- and NADPH-diaphorase in normal subjects and patients with methemoglobinemia. Biochem Biophys Res Commun 1967; 29:605.
26. Shirabe K, Yubisui T, Borgese N, Tang CY, Hultquist DE, Takeshita M: Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). J Biol Chem 1992;267:20416-20421.